8.9 C
Glasgow
Wednesday, March 4, 2026
spot_img

Ooops... Error 404

Sorry, but the page you are looking for doesn't exist.

Go to the homepage

Asahi Kasei to acquire Aicuris to accelerate growth in severe infectious diseases

biotech Jim Cornall -
Aicuris Anti-infective Cures AG has entered into a definitive agreement under which Asahi Kasei, through its wholly owned US subsidiary Veloxis Pharmaceuticals, Inc., will...

Promising results for rare paediatric epilepsy treatment

biotech Jim Cornall -
Cerecin Inc. has announced the publication of a phase 1/2a clinical study evaluating the investigational drug CER-0001 (tricaprilin) for the treatment of refractory infantile...

Next-generation flu vaccine development financed by EU

biotech Jim Cornall -
SK bioscience, IDT Biologika (IDT) and Vaxxas have been selected for phase 1 of a next-generation vaccine development initiative managed by the European Health...

Panome Bio looks to new metabolomics data solution for biomarker discovery and drug development

biotech Jim Cornall -
Panome Bio, a multi-omics contract research organisation, has launched MassID, a cloud-based computational platform designed to improve how researchers process and interpret untargeted LC/MS...

Valinor and Renew partner to generate largest neurological disease multi-omics dataset

biotech Jim Cornall -
Valinor Discovery and Renew Biotechnologies are set to collaborate to generate the largest clinical multi-omics dataset to date for neurological disorders. Designed to improve the...

New lab to speed up diagnostic innovation for biotech and pharma partners

biotech Jim Cornall -
ARUP Laboratories, the largest nonprofit reference laboratory in the US, has launched an Innovation Central Laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other...

Gallbladder cancer could soon be detected in blood

biotech Jim Cornall -
Researchers at Tezpur University in Assam, India, working with scientists at the University of Illinois Urbana-Champaign, have identified distinct chemical signatures in blood that...

Base to Base biotech podcast 48: GPCRs and beating neurodegenerative diseases

biotech Jim Cornall -
The conversations on this week’s podcast are with CEO of Merz Therapeutics, Stefan König, about a variety of neurodegenerative conditions and a botulinum neurotoxin,...
- Advertisement -spot_img

Latest Articles

Load more

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media